Skip to main content
. Author manuscript; available in PMC: 2023 Aug 29.
Published in final edited form as: J Hypertens. 2020 Jun 1;38(6):1080–1089. doi: 10.1097/HJH.0000000000002387

Figure 4. Monthly variation in cardio-cerebrovascular events morbidity.

Figure 4

A Cardio-cerebrovascular disease. B Cardiovascular disease. C MACE (major adverse cardiovascular events). D Stroke. To make the curve smoother, two calendar months are combined. Vertical lines indicate the corresponding 95% CI (confidence intervals). Numbers above confidence intervals are of mortalities (per 100000 person-years) and those below are the cases of various cardio-cerebrovascular events. Cardio-cerebrovascular events morbidities are calculated using population excluding those taking antihypertensive drugs.